Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V9HL
|
|||
| Former ID |
DNCL001930
|
|||
| Drug Name |
BMS-241027
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9] | Phase 1 | [1] | |
| Tauopathy [ICD-11: 6D85.Y] | Phase 1 | [1] | ||
| Company |
Bristol-Myers Squibb
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01492374) Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.